Nice | New treatments for BPH, MS and migraine

30th January 2014 by Louise Hudman

Sometimes NICE does technology appraisals and I always figure it’s nice to know what’s out there – even if we’re not doing it ourselves, if for no other reason than that I know what to say when a patient appears with a Daily Mail cutting… So here are a few on common problems…

Prostatic urethral lift implants

This guideline advises that these can be used. Basically inserts which hold up the prostatic lobes are placed via the urethra. This then opens the urethra up. The big advantage is a reduction in the side-effects that commonly come with TURP, such as loss of sexual function. However the effects are not as long lasting, so it is likely to be used as a holding measure…

Teriflunomide for relapsing-remitting MS

This guideline is about Teriflunomide, which is otherwise known as Aubagio. Most current medications in MS are injectables, but this is an oral medication. It is immunomodulating and reduces disability at 3m after a relapse of MS. There is no difference at 6m. One important note is that it takes 2 yrs to clear from the system and is teratogenic, so women using it must be carefully counseled.

Transcranial Magnetic Stimulation (TMS) for migraine

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"The quality and contents of the magazine are superb. It's wonderful that GP locums now have a voice and are seen as a vital part of the medical workforce."

Dr Irene Bainbridge

See the full list of features within our NASGP membership plans

Membership